Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease

Periodontology 2000

Volumn 14, Issue 1, 1997, Pages 112-143

  Gemmell, Erica ^a   Marshall, Roderick I ^a   Seymour, Gregory J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; INTERLEUKIN DERIVATIVE; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT;

ANIMAL; DISEASE PREDISPOSITION; DOWN REGULATION; HELPER CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PERIODONTITIS; PHYSIOLOGY; REVIEW; UPREGULATION;

ANIMALS; CYTOKINES; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; INTERLEUKINS; PERIODONTITIS; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 0031152114     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1997.tb00194.x     Document Type: Article

References (337)

1. Allison JP. CD27-B7 interactions in T-cell activation. Curr Opin Immunol 1994: 6: 414-419.
2. Angelini SM, Trevino AC, Novak MJ. Mechanisms of neutrophil immobilization by membrane vesicles of Porphyromonas gingivalis. J Dent Res 1994: 73: 347 (abstr 1961).
3. Anderson W. Human gene therapy. Science 1992: 256: 808-813.
4. Aoyagi T, Sugawara-Aoyagi M, Yamazaki K, Hara K. Interleukin 4 (IL-4) and IL-6-producing memory T-cells in peripheral blood and gingival tissues in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol Immunol 1995: 10: 304-310.
5. Arai H, Nomura Y, Kinoshita M, Shimizu H, Ono K, Goto H, Takigawa M, Nishimura F, Washio N, Kurihara H, Murayama Y. Response of human gingival fibroblasts to prostaglandins. J Periodont Res 1995: 30: 303-311.
6. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991: 88: 1445-1451.
7. Asnis L, Gaspari A. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995: 33: 393-410.
8. Attström R, Egelberg J. Emigration of blood neutrophils and monocytes into the gingival crevice. J Periodont Res 1970: 5: 48-55.
9. Attström R. Studies on neutrophil polymorphonuclear leukocytes at the dento-gingival junction in gingival health and disease. J Periodont Res 1971: 8(suppl): 1-15.
10. Audibert FM, Lise LD. Adjuvants: current status, clinical perspectives and future prospects. Immunol Today 1993: 14: 281-284.
11. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989: 9: 299-304.
12. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993: 5: 503-510.
13. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993: 14: 436-441.
14. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J, Chan H, Sigal E, Ramesha C. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1994: 1209: 130-139.
15. Bertolini DR, Nedwin GE, Bringman JS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of formation in vitro by human tumor necrosis factors. Nature 1986: 319: 516-518.
16. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985: 76: 2003-2011.
17. Bigler CF, Norris DA, Weston WL, Arend WP. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 1992: 98: 38-44.
18. Birkedal-Hansen H. Roles of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993: 28: 500-510.
19. Blau H, Springer M. Gene therapy - a novel form of drug delivery. N Engl J Med 1995: 333: 1204-1207.
20. Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1992: 13: 131-136.
21. Bohjanen PR, Okajima M, Hodes RJ. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc Natl Acad Sci U S A 1990: 87: 5283-5287.
22. Bookstein R, Demers W, Gregory R, Manevol D, Park J, Wills K. p53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer. Semin Oncol 1996: 23: 101-107.
23. Boyce S, Chan CC, Gordon R, Li CS, Rodger IW, Webb JK, Rupniak NM, Hill RG. L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacol 1994: 33: 1609-1611.
24. Brach MA, DeVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992: 80: 2920-2924.
25. Brown M, Hu-Li J, Paul WE. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. J Immunol 1988: 131: 504-511.
26. Caillon P, Saffar J. Improvement of gingival and alveolar bone status in periodontitis-affected hamsters treated with 15-methyl prostaglandin E1. J Periodont Res 1994: 29: 138-45.
27. Carpenter AB, Sully EC, Ranney RR, Bick PH. T-cell regulation of polyclonal B-cell activation induced by extracts of oral bacteria associated with periodontal diseases. Infect Immun 1984: 43: 326-336.
28. Carter LL, Dutton RW. Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996: 8: 336-342.
29. Cassatella MA, Gasperini S, Calzetti F, McDonald PP, Trinchieri G. Lipopolysaccharide-induced interleukin-8 gene expression in human granulocytes: transcriptional inhibition by interferon-gamma. Biochem J 1995: 310: 751-755.
30. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993: 178: 2207-2211.
31. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994: 179: 1695-1699.
32. Centrella M, McCarthy TL, Canalis E. Skeletal tissue and transforming growth factor β. FASEB J 1988: 2: 3066-3073.
33. Chan C, Boyce S, Brideau C, Ford Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M, Prasit P, Rasori R, Riendeau D, Roy D, Tagari P, Vickers P, Wong E, Rodger I. Pharmacology of a selective cyclooxygenase2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995: 274: 1531-1537.
34. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G. Induction of Interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991: 173: 869-879.
35. Chanmugam P, Feng L, Liou S, Jang BC, Boudreau M, Yu G, Lee JH, Kwon HJ, Beppu T, Yoshida M, Xia Y, Wilson C, Hwang D. Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J Biol Chem 1995: 270: 5418-5426.
36. Chen PB, Davern LB, Schifferle R, Zambon JJ. Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection. Infect Immun 1990: 58: 3394-3400.
37. Clagett JA, Page RC. Insoluble immune complexes and chronic periodontal diseases in man and the dog. Arch Oral Biol 1978: 23: 153-165.
38. Clemens MJ. In: Read AP, Brown T, ed. Cytokines. Oxford: Bios Scientific Publishers, 1991.
39. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferongamma. J Immunol 1986: 136: 949-954.
40. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986: 136: 4538-4541.
41. Cole KC, Seymour GJ, Powell RN. The autologous mixed lymphocyte reactions (AMLR) using periodontal lymphocytes. J Dent Res 1986: 65: 473, abstract no. 16.
42. Cole KC, Seymour GJ, Powell RN. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol 1987: 58: 569-573.
43. Colombo M, Rodolfo M. Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials. Cancer Immunol Immunother 1995: 41: 265-270.
44. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992: 80: 2012-2020.
45. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990: 86: 972-980.
46. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M. Increased levels of soluble tumor necrosis factors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992: 35: 1160-1169.
47. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ. A new cytokine receptor superfamily. Trends Biochem Sci 1990: 15: 265-270.
48. Crystal R, McElvaney N, Rosenfeld M, Chu C-S, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 1994: 8: 42-47.
49. Curiel D, Wagner E, Gotten M, Birnstiel M, Agarwal S, Li CM, Loechel S, Hu PC. High efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 1992: 3: 147-154.
50. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985: 162: 2163-2168.
51. De Maeyer E, De Maeyer-Guignard J. Interferon-γ. Curr Opin Immunol 1992: 4: 321-326.
52. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both Type 1 helper (Th1) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993: 150: 353-360.
53. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988: 140: 4193-4198.
54. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993: 150: 4754-4765.
55. De Waal Malefyt R, Figdor C, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monpcytes. J Immunol 1993: 151: 6370-6381.
56. De Waal Malefyt R, Yssel H, Roncarolo M-G, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992: 4: 314-320.
57. 2, thromboxane, and prostacyclin in periodontal tissues. J Periodont Res 1983: 18: 156-163.
58. Dietrich J, Goodson JM, Raisz LG. Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins 1975: 10: 231-240.
59. Dinarello CA. Interleukin-1. Rev Infect Dis 1984: 6: 51-95.
60. Dinarello CA. The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol Lett 1987: 16: 227-232.
61. Dinarello CA. The role of interleukin-1 in host responses to infectious diseases. Infect Agents Dis 1992: 1: 227-236.
62. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993: 328: 106-113.
63. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992: 148: 3133-3139.
64. Ding L, Linsley PS, Huang L-Y, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993: 151: 1224-1234.
65. Distel M, Mueller C, Bluhmki E, Fries J. Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 1996: 35(Suppl 1): 68-77.
66. Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Sehgal PK, Nathan DG, Clark SC. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986: 321: 872-875.
67. Dongari-Bagtzoglou A, Ebersole J. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodont Res 1996: 31: 90-98.
68. Donnelly RP, Fenton MJ, Finbloom DS, Gerrard TL. Differential regulation of IL-1 production in human monocytes by IFN-γ and IL-4. J Immunol 1990: 145: 569-575.
69. Drevlow B, Lovis R, Haag M, Sinacore J, Jacobs C, Blosch C, Beck C, Landay A, Moreland L, Pope R. Phase I study of recombinant human interleukin-1 receptor (RHUILIR) administered subcutaneously in patients with active rheumatoid arthritis. Arthritis Rheum 1994: 37: S339 (abstr 1070).
70. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990: 172: 737-744.
71. DuBois R, Awad J, Morrow J, Roberts L, Bishop P. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 1994: 93: 493-498.
72. Eastcott JW, Yamashita K, Taubman MA, Harada Y, Smith DJ. Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol Immunol 1994: 9: 284-289.
73. Ebersole J Singer R, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunogloblulins in GCF from healthy, gingivitis and periodontitis sites. J Periodont Res 1993: 28: 543-546.
74. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994: 5: 112-141.
75. 2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976: 11: 331-341.
76. El Attar T, Lin H. Prostaglandins in gingiva of patients with periodontal disease. J Periodontol 1981: 52: 16-19.
77. El Attar T, Lin H. Relative conversion of arachidonic acid through lipoxygenase and cyclooxygenase pathways by homogenates of diseased periodontal tissues. J Oral Pathol 1983: 12: 7-10.
78. El Attar T, Lin H, Tira D. Arachidonic acid metabolism in inflamed gingiva and its inhibition by anti-inflammatory drugs. J Periodontol 1984: 55: 536-539.
79. 2 antagonizes gingival fibroblast proliferation stimulated by interleukin-1β. Prostaglandins Leukotr Essen Fatty Acids 1993: 49: 847-850.
80. Elliott M, Maini R. Anti-cytokine therapy in rheumatoid arthritis. Baillière's Clin Rheumatol 1995: 9: 633-652.
81. Elliot M, Maini R, Feldman M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994: 344 (8930): 1105-1110.
82. Elliot M, Maini R, Feldman M, Long-Fox A, Charles P, Bijl H, Woody JN. Repeated therapy with monoclonal antibody to tumor necrosis factor á(cA2) in patients with rheumatoid arthritis. Lancet 1994: 344: 1125-1128.
83. Ellis SD, Tucci MA, Serio FG, Johnson RB. IL-12 in periodontal disease. J Dent Res 1996: 75: 322 (abstr 2440).
84. Engelhardt G, Bogel R, Schnitzler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism. II. In vivo findings. Biochem Pharmacol 1996: 51: 29-38.
85. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 1993: 150: 4754-4765.
86. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989: 142: 3857-3861.
87. Evans RT, Klausen B, Sojar HT, Bedi GS, Sfintescu C, Ramamurthy NS, Golub LM, Genco RJ. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun 1992: 60: 2926-2935.
88. + cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol 1993: 151: 38-47.
89. Ferkol T, Kaetzel C, Davis P. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. J Clin Invest 1993: 92: 2394-2400.
90. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988: 140: 1022-1027.
91. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991: 146: 3444-3451.
92. Frankenburg S, Kofsky Y, Gross A. In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection. Parasite Immunol 1993: 15: 509-512.
93. Freeman S, Abboud C, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The "bystander effect." Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993: 53: 5274-5283.
94. Fu JY, Masferrer JL, Seibert S, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990: 265: 16737-16740.
95. Fujihashi K, Kono Y, Yamamoto M, McGhee JR, Beagley K, Aicher WK, Kiyono H. Interleukin production by gingival mononuclear cells isolated from adult periodontitis patients. J Dent Res 1991: 70: 550 (abstr 2269).
96. + T cells in adult periodontitis. J Dent Res 1994: 73: 204 (abstr 818).
97. Gaffer A, Scherl D, Afflitto J, Coleman E. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995: 22: 480-484.
98. Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations J Immunol 1991: 146: 1750-1758.
99. 2 release from human monocytes. J Periodontol 1988: 59: 684-687.
100. 2 in the SHR aorta. Circ Res 1995: 76: 1003-1010.
101. Gemmell E, Feldner B, Seymour GJ. CD45RO and CD45RA positive cells in peripheral blood and periodontal lesions before and after stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. Oral Microbiol Immunol 1992: 7: 84-88.
102. Gemmell E, Kjeldsen M, Yamazaki K, Nakajima T, Aldred MJ, Seymour GJ. Cytokine profiles of Porphyromonas gingivalis-reactive T lymphocyte lines and clones derived from P. gingivalis-infected subjects. Oral Dis 1995: 1: 139-146.
103. Gemmell E, Seymour GJ. Interleukin 1, interleukin 6 and transforming growth factor-β production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J Periodont Res 1992: 28: 122-129.
104. Gemmell E, Seymour GJ. Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol 1994: 28-38.
105. Genco RJ, Mashimo PA, Krygier G, Ellison SA. Antibodymediated effects on the periodontium. J Periodontol 1974: 45: 330-337.
106. Genco RJ, Zambon JJ, Christersson LA. The origin of periodontal infections. Adv Dent Res 1988: 2: 245-259.
107. Geng Y, Blanco F, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995: 155: 796-801.
108. Ghezzi P, Dinarello CA. IL-1 induces IL-1. 3. Specific inhibition of IL-1 production by IFN-γ. J Immunol 1988: 140: 4238-4244.
109. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isajson PC, Siebert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 1995: 305(part 2): 479-484.
110. Gilboa E. Immunotherapy of cancer with genetically modified tumor vaccines. Semin Oncol 1996: 23: 101-107.
111. Goldhaber P. Tissue culture studies of bone as a model system for periodontal research. J Dent Res 1971: 50: 278-285.
112. Goldhaber P, Rabadjija L, Beyer WR, Kornhauser A. Bone resorption in tissue culture and its relevance to periodontal disease. J Am Dent Assoc 1973: 87: 1027-1033.
113. Golumbeck PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM. Treatment of established renal cancer by tumour cells engineered to secrete interleukin-4. Science 1991: 254: 713-716.
114. Gomes BD, Hausmann E, Wienfeld N, De Luca C. Prostaglandins: bone resorption stimulating factors released from monkey gingiva. Calcif Tissue Res 1976: 19: 285-293.
115. 2 levels and human periodontal disease. Prostaglandins 1974: 6: 81-85.
116. Graham BS, Henderson GS, Tang Y-W, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993: 151: 2032-2040.
117. Granowitz EV, Clark BD. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: IL-1 receptor antagonist inhibits IL-1 induced cytokine synthesis and blocks the binding of IL-1 to its type 11 receptor on human monocytes. Blood 1992: 79: 2356-2363.
118. Grimm E, Mazumder A, Zhang H, Rosenberg S. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982: 155: 1823-1841.
119. Griswold DE, Hillegass LM, Breton JJ, Esser KM, Adams JL. Differentiation in vivo of classical non-steroidal an tunflammatory drugs from cytokine-suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production. Drugs Exp Clin Res 1993: 19: 243-248.
120. Griswold DE, Marshall PJ, Lee JC, Webb EF, Hillegass LM, Wartell J, Newton J Jr, Hanna N. Pharmacology of the pyrroloimidazole, SK&F 105809. II. Antiinflammatory activity and inhibition of mediator production in vivo. Biochem Pharmacol 1991: 42: 825-831.
121. Grossman M, Raper S, Kozarsky K, Stein E, Engelhardt J, Muller D, Lupien PJ, Wilson JM. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet 1994: 6: 335-341.
122. Grove KL, Guo X, Liu SH, Gao Z, Chu CK, Cheng YC. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res 1995: 55: 3008-3011.
123. Hamblin AS. In: Male D, ed. Cytokines and cytokine receptors. Oxford: Oxford University Press, 1993.
124. Hammerberg C, Arend W, Fisher G, Chan L, Berger A, Haskill J, Voorhees J, Cooper K. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 1992: 90: 571-583.
125. Hanania E, Fu S, Zu Z, Hegewisch Becker S, Korbling M, Hester J, Durett A, Andreeff M, Mechetner E, Holzmayer T, Roninson I, Giles E, Berenson R, Heimfeld S, Deisscroth A. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. Gene Ther 1995: 2: 285-294.
126. Hanania E, Kavanagh J, Hortobagyi G, Giles R, Champlin R, Deisseroth A. Recent advances in the application of gene therapy to human disease. Am J Med 1995: 99: 537-552.
127. 2 regulates gingival mononuclear cell immunoglobulin production. J Periodontol 1995: 66: 222-227.
128. Harvey W, Bennett A. Prostaglandins in bone resorption. Boca Raton, FL: CRC Press, 1988.
129. Heasman P, Benn DK, Kelly P, Seymour R, Aitken D. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Periodontol 1993: 20: 457-464.
130. 2 and tumour necrosis factor α in experimental gingivitis in humans. J Periodont Res 1993: 28: 241-247.
131. Heasman P, Offenbacher S, Collins J, Edwards G, Seymour R. Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol 1993: 20: 732-728.
132. Heasman PA, Seymour R. The effect of a systemically-administered non-steroidal anti-inflammatory drug (flurbiprofen) on experimental gingivitis in humans. J Clin Periodontol 1989: 16: 551-556.
133. Heasman P, Seymour R, Kelly P. The effect of systemically-administered flurbiprofen as an adjunct to toothbrushing on resolution of experimental gingivitis. J Clin Periodontol 1994: 21: 166-170.
134. Hendley TM, Steed RB, Galbraith GMP. Interleukin-1β gene expression in human oral polymorphonuclear leukocytes. J Periodontol 1995: 66: 761-765.
135. Higuchi M, Aggarwal BB. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. J Biol Chem 1992: 267: 20892-20899.
136. Honig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Interleukin-1 beta (IL-1β) concentration in gingival tissue from periodontitis patients and healthy control subjects. J Periodont Res 1989: 24: 362-367.
137. Hoogerbrugge P, Vassen J, Beusechann V, Valerio D. Treatment of patients with SCID due to ADA deficiency by autologous transplantation of genetically-modified bone marrow cells. Hum Gene Ther 1992: 3: 553-558.
138. Howard M, O'Garra A. Biological properties of Interleukin 10. Immunol Today 1992: 13: 198-200.
139. Howell TH. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993: 64: 828-833.
140. Howells GL. Cytokine networks in destructive periodontal disease. Oral Dis 1995: 1: 266-270.
141. Hughes FJ, Howells GL Interleukin-6 inhibits bone formation in vitro. Bone Min 1993: 21: 21-28.
142. Hyams JS, Fitzgerald JE, Wyzga N, Muller R, Treem WR, Justinich CJ, Kreutzer DL Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1995: 21: 419-425.
143. + suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J Immunol 1993: 150: 2121-2128.
144. Isakson P, Siebert K, Masferrer J, Salvemini D, Lee L, Needleman P. Discovery of a better aspirin. Adv Prostaglandin Thromboxane Leukot Res 1995: 23: 49-54.
145. Ishii T, Mahanonda R, Seymour GJ. The establishment of human T cell lines reactive with specific periodontal bacteria. Oral Microbiol Immunol 1992: 7: 225-229.
146. Ito H-O, Shuto T, Takada H, Koga T, Aida Y, Hirata M, Koga T. Lipopolysaccharides from Porphyromonns gingivalis, Prevotella intermedia and Actinobacillus actinomycetem-comitans promote osteoclast differentiation in vitro. Arch Oral Biol 1996: 41: 439-444.
147. Jeannin P, Delneste Y, Life P, Gauchat JF, Kaiserlian D, Bonnefoy JY. Interleukin-12 increases interleukin-4 production by established human Th0 and Th2-like T cell clones. Eur J Immunol 1995: 25: 2247-2252.
148. + T lymphocyte migration. J Immunol 1993: 151: 4545-4551.
149. Jones D, Carlton D, McIntyre T, Zimmerman G, Prescott S. Molecular cloning of human prostaglandin endoperoxidase synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993: 268: 9049-9054.
150. Karatzas S, Novak MJ, Blieden TM. Cytokine production by Porphyromonas gingivalis-specific human T cells. J Dent Res 1996: 75: 322 (abstr 2435).
151. Kelso A. Cytokines in infectious disease. Aust Microbiol 1990: 11: 372-376.
152. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today 1995: 16: 374-379.
153. + T cells and clones activated in vivo and in vitro. Immunol Rev 1991: 123: 85-114.
154. Kesavalu L, Ebersole JL, Machen RL, Holt SC. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 1992: 60: 1455-1464.
155. Kimura S, Fugimoto N, Okada H. Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis. Infect Immun 1992: 59: 4418-4424.
156. Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970: 86: 1436-1440.
157. Klein T, Nusing RM, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994: 48: 1605-1610.
158. Knight D, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, Ghrayeb J. Construction and initial characterization of a mousehuman chimeric anti-TNF antibody. Mol Immunol 1993: 30: 1443-1453.
159. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF) a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989: 70: 827-845.
160. Koç ON, Allay JA, Lee K, Davis BM, Reese JS, Gerson SL. Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance. Semin Oncol 1996: 23: 46-65.
161. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992: 90: 772-779.
162. Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, Takai M, Ono Y, Taniguchi Y, Hara K. In vivo administration of IL-1β accelerates silk ligature-induced alveolar bone resorption in rats. J Oral Pathol Med 1995: 24: 420-434.
163. Kujubu D, Fletcher B, Varnum B, Lim R, Herschman H. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase gene. J Biol Chem 1991: 266: 12866-12872.
164. Kupper TS, Ballard DW, Chua AO, McGuire JS, Flood PM, Horowitz MC, Langdon R, Lightfoot L, Gubler U. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin-1α and β mRNA; keratinocyte epidermal cell-derived thymocytes activating factor is identical to interleukin-1. J Exp Med 1986: 164: 2095-2100.
165. Kutsch CL, Norris DA, Arend WP Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol 1993: 101: 79-85.
166. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today 1996: 17: 214-217.
167. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxidase H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994: 271: 927-934.
168. Larkin M. Promising results reported for lung cancer gene therapy. Lancet 1996: 348: 671.
169. Lattime E, Lee S, Eisenlohr L, Mastrangelo M. In situ cytokine gene transfection using vaccinia virus vectors. Semin Oncol 1996: 23: 88-100.
170. Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin 1. Cytokines with multiple overlapping biological activities. Lab Invest 1987: 3: 234.
171. Lee JC, Young PR. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 1996: 59: 152-157.
172. Lee S, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992: 267: 25934-25938.
173. Lewis RA. Interactions of eicosanoids and cytokines in immune regulation. Adv Prostaglandin Thromboxane Leukot Res 1990: 20: 170-178.
174. Lloyd AR, Oppenheim JJ. Poly's lament: The neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992: 13: 169-172.
175. Loning T, Albers H, Lisboa B, Burkhardt A, Caselitz J. Prostaglandin E and local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. J Periodont Res 1980: 15: 525-35.
176. Lopatin DE, Blackburn E. Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 1992: 7: 332-337.
177. Lundgren M, Persson U, Larsson P, Magnusson C, Smith CIE, Hammarström L, Severinson E. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 1989: 19: 1311-1315.
178. Lupton S, Printon L, Kalberg V, Overall R. Dominant positive and negative selection using a hygromycin phosphotransferase thymidine kinase fusion gene. Mol Cell Biol 1991: 11: 3374-3378.
179. MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA. Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking, J Periodontol 1992: 63: 908-913.
180. Mahanonda R, Seymour GJ, Powell LW, Good MF, Halliday JW. Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria. Oral Microbiol Immunol 1991: 6: 221-227.
181. Mangan DF, Mergenhagen SE, Wahl SM. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol 1993: 64: 461-466.
182. Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 1992: 148: 1812-1816.
183. Manhart SS, Reinhardt RA, Payne JB, Seymour GJ, Gemmell E, Dyer JK, Petro TM. Gingival cell IL-2 and IL-4 in early-onset periodontitis. J Periodontol 1994: 65: 807-813.
184. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K Conlon P, Hopp T, Cosman D. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985: 315: 641-647.
185. Marks Jr S, Miller S. Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo. J Oral Pathol 1988: 17: 500-505.
186. Marks S, Miller S. Local delivery of prostaglandin E1 induces periodontal regeneration in adult dogs. J Periodont Res 1994: 29: 103-108.
187. Martin D, Near SL. Protective effect of the interleukin-1 receptor antagonist (IL-lra) on experimental allergic encephalomyelitis in rats. J Neuroimmunol 1995: 61: 241-245.
188. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1α and -1β in gingival crevicular fluid: implication for the pathogenesis of periodontal disease. J Periodont Res 1990: 25: 156-163.
189. Mastrangelo M, Berd D, Nathan F, Lattime E. Gene therapy for human cancer: an essay for clinicians. Sem Oncol 1996: 23: 4-21.
190. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger-RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunology 1992: 76: 42-47.
191. Matsuki Y, Yamamoto T, Hara K. Localization of interleukin-1 (IL-1) mRNA-expressing macrophages in human inflamed gingiva and IL-1 activity in gingival crevicular fluid. J Periodont Res 1993: 28: 35-42.
192. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994: 83: 1988-1997.
193. McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J Aversa G, Sato A, Dang W, Cocks BG, Menon S, de Vries JE, Banchereau J, Zurawski G. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A 1993: 90: 3735-3739.
194. Meghji S, Henderson B, Wilson M. High-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown. J Periodont Res 1993: 28: 115-121.
195. Meikle MC, Heath JK, Reynolds JJ. Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. J Oral Pathol 1986: 15: 239-250.
196. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival fibroblasts degrade type 1 collagen films when stimulated with tumor necrosis factor and interleukin 1. Evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989: 24: 207-213.
197. Mendieta C, Reeve C, Romero J. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. J Periodontol 1985: 56: 44-47.
198. + cytolytic clones. Eur J Immunol 1984: 14: 1066-1069.
199. Mitchell J, Akarasereenont P, Thiemermann C, Flower R, Vane J. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1993: 90: 11693-11697.
200. Miyamoto T, Ogino N, Yamamoto S, Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 1976: 251: 2629-2636.
201. 2 on alveolar bone loss-histometric analysis. J Periodontol 1992: 63: 405-411.
202. Modlin RL, Nutman TB. Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol 1993: 5: 511-517.
203. Moore MA. The clinical use of colony stimulating factors. Annu Rev Immunol 1991: 9: 159-191.
204. Moreland L, Margolies G, Heck L, Saway P, Jacobs C, Beck C, Blosch C, Kooperman W. Soluble tumor necrosis factor receptor (sTNFR) results of a phase I dose-escalation study in patients with rheumatoid arthritis. Arthritis Rheum 1994: 37: S295 (abstr 813).
205. Morris AG. Interferons Immunology 1988: 1(suppl): 43-45.
206. Mosmann TR. Cytokines: is there biological meaning? Curr Opin Immunol 1991: 3: 311-314.
207. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989: 7: 145-173.
208. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996: 17: 138-146.
209. Mulligan R. The basic science of gene therapy. Science 1993: 260: 926-932.
210. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodont Res 1991: 26: 213-217.
211. Nabel G, Nabel E, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Direct gene transfer with DNA liposome complexes in melanoma: Expression, biologic activity and lack of toxicity in humans. Proc Natl Acad Sci U S A 1993: 90: 11307-11311.
212. 2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994: 21: 327-333.
213. Nathan C, Kaplan G, Levis W, Nusrat A, Witmer M, Sherwin S, Job C, Horowitz C, Steinmann R, Cohn Z. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med 1986: 315: 6-15.
214. 2 synthesis. J Periodont Res 1996: 31: 131-134.
215. Nicola NA. Guidebook to cytokines and their receptors. Oxford: Oxford University Press, 1994.
216. Nienhuis A, Donahue R, Karlsson S, Clark S, Agricola B, Antinoff N, Pierce J, Turner P, Anderson W, Nathan D. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987: 80: 573-577.
217. Nishihara T, Ohsaki Y, Ueda N, Saito N, Mundy GR. Mouse interleukin-1 receptor antagonist induced by Actino-bacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation. Infect Immun 1994: 62: 390-397.
218. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR Jr. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995: 117: 648-655.
219. Offenbacher S, Farr D, Goodson J. Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol 1981: 8: 369-367.
220. Offenbacher S, Odle B, Braswell L, Johnson H, Hall C, McClure H, Orkin J, Strobert E, Green M. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodont Res 1989: 24: 63-74.
221. 2 synthesis with selected agents. Agents Actions 1990: 29: 232-238.
222. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986: 21: 101-112.
223. Offenbacher S, Williams R, Jeffcoat M, Howell T, Odle B, Smith M, Hall C, Johnson H, Goldhaber P. Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss. J Periodont Res 1992: 27: 207-213.
224. O'Garra A. Peptide regulatory factors. Interleukins and the immune system. Part 1. Lancet 1989: 1: 943-946.
225. O'Garra A. Peptide regulatory factors. Interleukins and the immune system 2. Lancet 1989: 1: 1003-1005.
226. Ogawa T, Kushumoto Y, Hamada S, McGhee JR, Kiyono H. Bacteroides gingivalis-specific serum IgG and IgA sub-class antibodies in periodontal disease. Clin Exp Immunol 1990: 82: 318-325.
227. Ogiso B, Hughes F, Davies J, McCulloch A. Fibroblastic regulation of osteoblast function by prostaglandins. Cell Signal 1992: 4: 627-639.
228. Okuda K, Kato T, Naito Y, Kikuchi Y, Takazoe I. Susceptibility of Bacteroides gingivalis to bactericidal activity of human serum. J Dent Res 1986: 65: 1024-1027.
229. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991: 9: 617-648.
230. Orange JS, Wolf SF, Biron CA. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994: 152: 1253-1264.
231. Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis. Cytokine 1991: 3: 277-283.
232. O'Sullivan M, Chilton F, Huggins E, McCall C. Lipopolysaccharide priming of alveolar macrophages for enhanced sythesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992: 267: 14547-14550.
233. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991: 26: 230-242.
234. + T cells by conventional antigen and M1s superantigen. Proc Natl Acad Sci U S A 1991: 88: 2736-2739.
235. Payne JB, Reinhardt RA, Masada MP, DuBois LM, Allison AC. Gingival crevicular fluid IL-8; correlation with local IL-1 levels and patient estrogen status. J Periodont Res 1993: 28: 451-453.
236. Perregaux DG, Dean D, Cronan M, Connelly P, Gabel C A. Inhibition of interleukin-1 beta production by SKF86002: idence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol 1995: 48: 433-442.
237. Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M, Page RC. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun 1994: 62: 1026-1031.
238. Perussia B, Chan SH, D'Andrea A, Tsuji K, Santoli D, Pospisil M, Young D, Wolf SF, Trinchieri G. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol 1992: 149: 3495-3502.
239. Pfeilschifter J. Transforming growth factor-β. In: Habenicht A, ed. Growth factors, differentiation factors, and cytokines. Berlin: Springer-Verlag, 1990: 56-64.
240. Pilon M, Williams-Miller C, Cox DS. Interleukin-2 levels in gingival crevicular fluid in periodontitis. J Dent Res 1991: 70: 550 (abstr 2270).
241. Platt D, Crosby RG, Dalbow MH. Evidence for the presence of immunoglobulins and antibodies in inflamed periodontal tissues. J Periodontol 1970: 41: 215-222.
242. Podolsky DK. Inflammatory bowel disease. Part 1. N Engl J Med 1991: 325: 928-937.
243. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993: 14: 270-274.
244. Prabhu A, Michalowicz, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J Periodontol 1996: 67: 515-522.
245. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1993: 90: 3730-3734.
246. Qwarnström EE, MacFarlane SA, Page RC. Effects of interleukin-1 on fibroblast extracellular matrix, using a 3-dimensional culture system. J Cell Physiol 1989: 139: 501-508.
247. Raisz LG. Physiologic and pharmacologic regulation of bone resorption. N Engl J Med 1970: 282: 909-916.
248. Rankin E, Choy E, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, Panayi GS. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 1995: 34: 334-342.
249. Re F, Mengozzi M, Muzio M, Dinarello CA, Mantovani A, Colotta F. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur J Immunol 1993: 23: 570-573.
250. Reddi K, Wilson M, Nair S, Poole S, Henderson B. Comparison of the pro-inflammatory cytokine-stimulating activity of the surface-associated proteins of periodontopathic bacteria. J Periodont Res 1996: 31: 120-130.
251. Reinhardt RA, Masada MP, Kaldahl WB, DuBois LM, Kornman KS, Choi JI, Kalkwarf KL, Allison AC. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993: 20: 225-231.
252. Reinhardt RA, McDonald TL, Bolton RW, Dubois LM, Kaldahl WB. IgG subclasses in gingival crevicular fluid from active versus stable periodontal sites. J Periodontol 1989: 60: 44-50.
253. Richards D, Rutherford RB. The effects of interleukin-1 on llagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblast. Arch Oral Biol 1988: 33: 237-243.
254. Riddell S, Russer P, Greenberg P. Cytotoxic T cells specific for CMV: a potential therapy for immunocompromised patients. Rev Infect Dis 1991: 13(suppl 11): S966-S973.
255. Rissen R, Rahimizadeh H, Blessing E, Takeshita S, Barry J, Isner J. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 1993: 4: 749-758.
256. + T cells toward a Th1 or Th2 functional phenotype. J Immunol 1992: 148: 47-54.
257. + T cells producing IL-2 or IL-4. J Immunol 1992: 148: 1031-1036.
258. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992: 98: 279-285.
259. Roodman GD. Interleukin-6: an osteotropic factor? J Bone Miner Res 1992: 7: 475-478.
260. Rosa F, Fellows M. Effect of gamma-interferon on MHC antigens. Immunol Today 1984: 9: 261-262.
261. Rosenberg S, Lotze M, Muul L, Leitman S, Chang A, Ettinghausen S, Matory Y, Skibber J, Shiloni E, Vetto J, Seipp C, Simpson C, Reichert C. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985: 313: 1485-1492.
262. Rosenkoetta M, Reder AT, Oger JJ, Antel JP. T-cell regulation of polyclonally induced immunoglobulin secretion in humans. J Immunol 1984: 132: 1779-1783.
263. Rossomando EF, Kennedy JE, Hadjimichael J. Tumor necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990: 35: 431-434.
264. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 1992: 89: 1890-1893.
265. Saffar J, Lasfargues J. A histometric study of the effect of indomethacin and calcitonin on bone remodelling in hamster periodontitis. Arch Oral Biol 1984: 29: 555-558.
266. Saito S, Ngan P, Saito M, Lanese R, Shanfeld J, Davidovitch Z. Interactive effects between cytokines on PGE production by human periodontal ligament fibroblasts in vitro. J Dent Res 1990: 69: 1456-1462.
267. Saito S, Rosol T, Saito M, Ngan P, Shanfeld J, Davidovitch Z. Bone-resorbing activity and prostaglandin E produced by human periodontal ligament cells in vitro. J Bone Miner Res 1990: 5: 1013-1018.
268. Saito S, Saito M, Ngan P, Lanese R, Shanfeld J, Davidovitch Z. Effects of parathyroid hormone and cytokines on prostaglandin E synthesis and bone resorption by human periodontal ligament fibroblasts. Arch Oral Biol 1990: 35: 845-855.
269. + T cell clones. Science 1991: 254: 279-282.
270. Scharton Kersten T, Scott P. The role of the innate imne response in Th1 cell development following Leishmania major infection. J Leukoc Biol 1995: 57: 515-522.
271. Schendel D, Gansbacher B. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumour cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Cancer Res 1993: 53: 4020-4025.
272. Schenk K. IgG, IgA and IgM serum antibodies against lipopolysaccharide from Bacteroides gingivalis in periodontal health and disease. J Periodont Res 1985: 20: 368-377.
273. Schenk K, Michaelsen TE. IgG subclass distribution of serum antibodies against lipopolysaccharide from Bacteroides gingivalis in periodontal health and disease. APMIS 1987: 95: 41-46.
274. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995: 108: 1434-1444.
275. Schroeder HE. Transmigration and infiltration of leukocytes in human junctional epithelium. Acta Odontol Scand 1973: 17: 6.
276. + T helper cell subsets. Curr Opin Immunol 1993: 5: 391-397.
277. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991: 12: 346-348.
278. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 1994: 91: 12013-12017.
279. Seymour GJ. Possible mechanisms involved in the immunoregulation of chronic inflammatory periodontal disease. J Dent Res 1987: 66: 2-9.
280. Seymour GJ. Importance of the host response in the periodontium. J Clin Periodontol 1991: 18: 421-426.
281. Seymour GJ, Cole KL, Powell RN, Lewins E, Cripps AW, Clancy RL. Interleukin-2 production and bone resorption activity by unstimulated lymphocytes extracted from chronically inflamed human periodontal tissues. Arch Oral Biol 1985: 30: 481-184.
282. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodont Res 1993: 28: 478-486.
283. 2, IL-1α, IL-6, and TNFα by adherent mononuclear cells from early onset periodontitis patients. J Periodontol 1994: 65: 139-146.
284. 2 secretion, cell maturation, and CD14 expression by monocyte-derived macrophages from localized juvenile periodontitis patients. J Periodontol 1996: 67: 224-228.
285. + T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol 1991: 147: 2713-2716.
286. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL Morse HC, Shearer GM. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992: 127: 181-204.
287. Simmons D, Levy D, Yannoni Y, Erikson R. Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci U S A 1989: 86: 11778-11782.
288. Slots J, Genco RJ. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization survival and tissue destruction. J Dent Res 1984: 63: 412-421.
289. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann N Y Acad Sci 1994: 744: 50-57.
290. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987: 236: 944-947.
291. Spits H, Yssel H, Takebe Y, Arai N, Yokota T, Lee F, Arai K, Banchereau J, De Vries J. Recombinant interleukin 4 promotes the growth of human T cells. J Immunol 1987: 139: 1142-1147.
292. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987: 138: 1464-1468.
293. Stashenko P, Fujiyoshie P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991: 18: 548-554.
294. Stein SH, Hendrix CL Interleukin-10 promotes anti-collagen antibody production in gingival mononuclear cells. J Dent Res 1996: 75: 158 (abstr 1122).
295. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991: 5: 171-177.
296. Suzuki JB, Risom L, Falkler WA Jr, Collison C, Bowers G. Effect of periodontal therapy on spontaneous lymphocyte response and neutrophil chemotaxis in localized and generalized juvenile periodontitis patients. J Clin Periodontol 1985: 12: 124-134.
297. Symons JA, Young PR, Duff GW. Soluble type 11 interleukin 1 (IL-I) receptor binds and blocks processing of IL-I beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A 1995: 92: 1714-1718.
298. Takahashi K, Takashiba S, Nagai A, Takigawa M, Myoukai F, Kurihara H, Murayama Y. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J Periodontol 1994: 65: 147-153.
299. Takeichi O, Taubman MA, Haber J, Smith DJ, Moro I. Cytokine profiles of CD4 and CD8 T cells isolated from adult periodontitis gingivae. J Dent Res 1994: 73: 205 (abstr 1549).
300. 2 inhibits interleukin-6 release but not transcription in human gingival fibroblasts stimulated with interleukin-Iß or tumor necrosis factor-α. J Periodontol 1994: 65: 1122-1127.
301. Tanaka K, Aikawa Y, Kawasaki H, Asaoka K, Inaba T, Yoshida C. Pharmacological studies on 3-formylamino-7-methylsulfonylarnino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6. J Pharmacobiodyn 1992: 15: 649-655.
302. Tanaka K, Makino S, Shimotori T, Aikawa Y, Inaba T, Yoshida C. Pharmacological studies of the new antiinflammary agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4′-1-benzopyran-4-one: effect on the arachidonic acid cascades. Arzneimittelforschung 1992: 42: 945-950.
303. Taubman MA, Stoufi ED, Ebersole JL, Smith DJ. Phenotypic studies of cells from periodontal disease tissue. J Periodont Res 1984: 19: 587-590.
304. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumour effect of interleukin-4. Science 1992: 257: 548-551.
305. Te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990: 76: 1392-1397.
306. Tew JG, Engel D, Mangan D. Polyclonal B-cell activation in periodontitis. J Periodont Res 1989: 24: 225-241.
307. Thomson BN, Mundy GR, Chambers TJ. Tumor necrosis factors alpha and beta induce osteoblastic bone resorption. J Immunol 1987: 138: 775-779.
308. Tokoro Y, Yamamoto T, Hara K. IL-1β mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva. J Oral Pathol Med 1996: 25: 225-231.
309. Tonetti MS, Freiburghaus K, Lang NP, Bickel M. Detection of IL-8 and matrix metalloproteinase transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodont Res 1993: 28: 511-513.
310. Tonetti MS, Imboden MA, Gerber L, Lang NP Laissue J, Mueller C. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 1994: 62: 4005-4014.
311. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993: 14: 335-337.
312. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985: 6: 131-136.
313. Van Dyke TE, Bartholomew E, Genco RJ, Slots J, Levine MJ. Inhibition of neutrophil chemotaxis by soluble bacterial factors. J Periodontol 1982: 53: 502-508.
314. Van Dyke TE, Lester MA, Shapira L. The role of the host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 1993: 64(suppl): 792-806.
315. Vane J, Bottling R. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 1996: 25(suppl 102): 9-21.
316. Vogel R, Schneider L, Goteiner D. The effects of a topically-active non-steroidal anti-inflammatory drug on ligature-induced periodontal disease in the squirrel monkey. J Clin Periodontol 1986: 13: 139-144.
317. Wagner E, Gotten M, Foisner R, Birnstiel M. Transferrin-polycation-DNA complexes: the effect of poly-cations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci U S A 1991: 88: 4255-4259.
318. Wallner BP, Mattaliano RJ, Hession C, Gate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browning JL, Ramachandran KL, Pepinsky RB. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potent anti-inflammatory activity. Nature 1986: 320: 77-81.
319. Walsh LJ, Stritzel F, Yamazaki K, Bird PS, Gemmell E, Seymour GJ. Interleukin-1 and interleukin-1 inhibitor production by human adherent cells stimulated with periodontopathic bacteria. Arch Oral Biol 1989: 34: 679-683.
320. Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993: 20: 259-262.
321. Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun 1992: 60: 2194-2200.
322. Williams R, Jeffcoat M, Howell T, Rolla A, Stubbs, Teoh K, Reddy M, Goldhaber P. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989: 60: 485-190.
323. Williams TJ, Peck MJ. Role of prostaglandin-mediated vasodilation in inflammation. Nature 1977: 270: 530-532.
324. Wills D, Maneval P, Menzel M, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM, Johnson DE, Anderson SC, Wen SF, Bookstein R, Shapard H, Gregory R. Development and characterization of recombinant adenovirus encoding human p53 for gene therapy of cancer. Hum Gene Ther 1994: 5: 1079-1088.
325. Wilson M, Kamin S, Harvey W. Bone resorbing activity of purified capsular material from Actinobacillus actinomycetemcomitans. J Periodont Res 1985: 20: 484-491.
326. Winning T, Gemmell E, Polak B, Savage NW, Walsh LW, Seymour GJ. Expression of CD1a on monocytes cultured with supernatants from periodontally diseased gingival epithelial cells. Oral Dis 1996: 2: 247-252.
327. Wolff J, Malone R, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. Direct gene transfer into mouse muscle in vivo. Science 1990: 247: 1465-1468.
328. Xu Amano J, Aicher WK, Taguchi T, Kiyono H, McGhee JR. Selective induction of Th2 cells in murine Peyer's patches by oral immunisation. Int Immunol 1992: 4: 433-445.
329. Xu Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S, McGhee JR. Helper T cell subsets for immunoglobulin A responses: oral immunisation with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993: 178: 1309-1320.
330. Yamamoto M, Fujihashi K, Hiroi T, McGhee JR, Van Dyke TE, Kiyono H. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodont Res 1997: 32: 115-119.
331. Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect Immun 1991: 59: 1529-1534.
332. Yamazaki K, Nakajima T, Aoyagi T, Hara K. Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease. J Periodont Res 1994: 28: 324-334.
333. Yamazaki K, Nakajima T, Hara K. Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol 1995: 99: 384-391.
334. Yamazaki K, Polak B, Bird PS, Gemmell E, Hara K, Seymour GJ. Effects of periodontopathic bacteria on IL-1 and IL-1 inhibitor production by human polymorphonuclear neutrophils. Oral Microbiol Immunol 1989: 4: 193-198.
335. Yavuzyilmaz E, Yamalik N, Bulut S, Özen S, Ersoy F, Saatçi O. The gingival crevicular fluid interleukin-1β and tumour necrosis factor-α levels in patients with rapidly progressive periodontitis. Aus Dent J 1995: 40: 46-49.
336. Yucel-Lindberg T, Ahola H, Nilsson S, Carlstedt-Duke J, Modeer T. Interleukin-1β induces expression of cyclooxynase-2 mRNA in human gingival fibroblasts. Inflammation 1995: 19: 549-560.
337. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994: 15: 19-26.